Gemcitabine and Cisplatin as Neo-Adjuvant for Cholangiocarcinoma Patients Prior to Liver Transplantation: Case-Series

Background: The management of cholangiocarcinoma is continually reviewed on a current evidence basis to develop practice guidelines and consensus statements. However, the standardized treatment guidelines are still unclear for cholangiocarcinoma patients who are listed for liver transplantation. We...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdelrahim, Maen, Al-Rawi, Hadeel, Esmail, Abdullah, Xu, Jiaqiong, Umoru, Godsfavour, Ibnshamsah, Fahad, Abudayyeh, Ala, Victor, David, Saharia, Ashish, McMillan, Robert, Al Najjar, Ebtesam, Bugazia, Doaa, Al-Rawi, Maryam, Ghobrial, Rafik M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139862/
https://www.ncbi.nlm.nih.gov/pubmed/35621680
http://dx.doi.org/10.3390/curroncol29050290

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139862/
https://www.ncbi.nlm.nih.gov/pubmed/35621680
http://dx.doi.org/10.3390/curroncol29050290

Ejemplares similares